The largest single cell perturbation dataset to-date will be generated and released open source in a new team effort.

ILMN's Connected Multiomics, launched after early user input, advances precision health research and may boost the stock.

The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).

Abstract: Spatial transcriptomics has emerged as a transformative technology for mapping gene expression within tissue contexts, offering unprecedented insights into disease mechanisms. However, ...

Illumina, whose EMEA head office is at Granta Park in Cambridge, has released Illumina Connected Multiomics, a powerful cloud ...

The "In Situ Hybridization Market Report by Product, Technique, Application, End User, Countries and Company Analysis ...

Study reveals how maternal stress impacts fetal brain development, highlighting sex-specific vulnerabilities and potential ...

Illumina, Inc. (NASDAQ: ILMN) today announced the release of Illumina Connected Multiomics, a powerful cloud-based research ...